Podocalyxin is a key negative regulator of human endometrial epithelial receptivity for embryo implantation.
Podocalyxin is a key negative regulator of human endometrial epithelial receptivity for embryo implantation.
复制标题
Podocalyxin 是人类子宫内膜上皮对胚胎植入容受性的关键负调节因子。
DOI:
10.1093/humrep/deab032
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Nie,Guiying
中科院分区:
文献类型:
--
作者:
Paule,SarahG;Heng,Sophea;Samarajeewa,Nirukshi;Li,Ying;Mansilla,Mary;Webb,AndrewI;Nebl,Thomas;Young,StevenL;Lessey,BruceA;Hull,MLouise;Scelwyn,Maxine;Lim,Rebecca;Vollenhoven,Beverley;Rombauts,LukJ;Nie,Guiying
STUDY QUESTIONHow is endometrial epithelial receptivity, particularly adhesiveness, regulated at the luminal epithelial surface for embryo implantation in the human?SUMMARY ANSWERPodocalyxin (PCX), a transmembrane protein, was identified as a key negative regulator of endometrial epithelial receptivity; specific downregulation of PCX in the luminal epithelium in the mid-secretory phase, likely mediated by progesterone, may act as a critical step in converting endometrial surface from a non-receptive to an implantation-permitting state.WHAT IS KNOWN ALREADYThe human endometrium must undergo major molecular and cellular changes to transform from a non-receptive to a receptive state to accommodate embryo implantation. However, the fundamental mechanisms governing receptivity, particularly at the luminal surface where the embryo first interacts with, are not well understood. A widely held view is that upregulation of adhesion-promoting molecules is important, but the details are not well characterized.STUDY DESIGN, SIZE, DURATIONThis study first aimed to identify novel adhesion-related membrane proteins with potential roles in receptivity in primary human endometrial epithelial cells (HEECs). Further experiments were then conducted to determine candidates’in vivoexpression pattern in the human endometrium across the menstrual cycle, regulation by progesterone using cell culture, and functional importance in receptivity usingin vitrohuman embryo attachment and invasion models.PARTICIPANTS/MATERIALS, SETTING, METHODSPrimary HEECs (n = 9) were isolated from the proliferative phase endometrial tissue, combined into three pools, subjected to plasma membrane protein enrichment by ultracentrifugation followed by proteomics analysis, which led to the discovery of PCX as a novel candidate of interest. Immunohistochemical analysis determined thein vivoexpression pattern and cellular localization of PCX in the human endometrium across the menstrual cycle (n = 23). To investigate whether PCX is regulated by progesterone, the master driver of endometrial differentiation, primary HEECs were treated in culture with estradiol and progesterone and analyzed by RT-PCR (n = 5) and western blot (n = 4). To demonstrate that PCX acts as a negative regulator of receptivity, PCX was overexpressed in Ishikawa cells (a receptive line) and the impact on receptivity was determined usingin vitroattachment (n = 3–5) and invasion models (n = 4–6), in which an Ishikawa monolayer mimicked the endometrial surface and primary human trophoblast spheroids mimicked embryos. Mann–Whitney U-test and ANOVA analyses established statistical significance at *P≤ 0.05 and **P≤ 0.01.MAIN RESULTS AND THE ROLE OF CHANCEPCX was expressed on the apical surface of all epithelial and endothelial cells in the non-receptive endometrium, but selectively downregulated in the luminal epithelium from the mid-secretory phase coinciding with the establishment of receptivity. Progesterone was confirmed to be able to suppress PCX in primary HEECs, suggesting this hormone likely mediates the downregulation of luminal PCXin vivofor receptivity. Overexpression of PCX in Ishikawa monolayer inhibited not only the attachment but also the penetration of human embryo surrogates, demonstrating that PCX acts as an important negative regulator of epithelial receptivity for implantation.LIMITATIONS, REASONS FOR CAUTIONPrimary HEECs isolated from the …